Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-26-053338
Filing Date
2026-05-07
Accepted
2026-05-07 16:17:07
Documents
42
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0287417-10q_inmune.htm   iXBRL 10-Q 385693
2 CERTIFICATION ea028741701ex31-1.htm EX-31.1 10539
3 CERTIFICATION ea028741701ex31-2.htm EX-31.2 10688
4 CERTIFICATION ea028741701ex32-1.htm EX-32.1 4176
5 CERTIFICATION ea028741701ex32-2.htm EX-32.2 4239
  Complete submission text file 0001213900-26-053338.txt   2782804

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inmb-20260331.xsd EX-101.SCH 22386
7 XBRL CALCULATION FILE inmb-20260331_cal.xml EX-101.CAL 26692
8 XBRL DEFINITION FILE inmb-20260331_def.xml EX-101.DEF 97213
9 XBRL LABEL FILE inmb-20260331_lab.xml EX-101.LAB 224519
10 XBRL PRESENTATION FILE inmb-20260331_pre.xml EX-101.PRE 176038
46 EXTRACTED XBRL INSTANCE DOCUMENT ea0287417-10q_inmune_htm.xml XML 225397
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 26953613
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)